Skip to main navigation menu Skip to main content Skip to site footer

Classical Paracoccidioidomicosis with skin component of lacaziosis or Jorge Lobo disease

Paracoccidioidomicosis clásica con componente cutáneo de lacaziosis o enfermedad de Jorge Lobo




Section
Presentación de casos

How to Cite
Classical Paracoccidioidomicosis with skin component of lacaziosis or Jorge Lobo disease.
rev. colomb. neumol. [Internet]. 2007 Mar. 1 [cited 2024 Nov. 24];19(1):18-23.

DOI
license
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Rafael Henriquez J.
    Giovani Lastra G.
      Luis Fernando Durán G.
        Jairo Sandoval S.

          61 year old male patient living in a rural area who presents a parakeloidean lesion of right hemi-face, that progresses with an active ulcerous, crusty, papilomatous border from the around the ear region towards the middle of the facial mass involving the outer part of the nostrils, chin, etc. The skin clinical aspect of this classical paracoccidomycosis that is very similar to lacaziosisor keloid paracoccidiomycosis, or ín other words, Jorge Lobo's disease.


          Article visits 15 | PDF visits 19


          Downloads

          Download data is not yet available.
          1. Lacaz, CS. Manual de Micología Médica, 3 ed, Rio de JaneiroSao Paulo: Livraria Atheneu S.A., 1960, pp 242-305.
          2. Fava Netto C. Estudos Quantitativos Sobre a Fixacao do Complemento na Blastomicose Sul-Americana con Antigeno Polisaccaridico, Thesis, University of Sao Paulo, 1955.
          3. Lobo J. Um Caso de blatomicose produzido por una especie nova, encontrada en Recife, Rev Med Pernambuco 1:763, 1931.
          4. Campos-Aasen |. Blastomicosis queloidea o enfermedad de Jorge Lobo en Venezuela, Derm Venez 3:215, 1958.
          5. Lacaz CS. South American Blastomycosis, An Fac Med Sao Paulo 1955-1956; 29:1-120.
          6. Angulo A.1971. Anatomo-Clinical aspects of paracoccidioidomycosis. Ref. 41, pp 129-133.
          7. Borrero RJ. Restrepo A. et al. 1965. Blastomicosis suramericana de forma pulmonar pura. Antioquia Med; 15:503-515.
          8. Calle VG. 1971. Dermatological aspects of paracoccidioidomycosis. Ref. 41, pp. 118-121.
          9. Negroni P, and Negroni R. 1968. Aspectos clinicos e inmunológicos de la blas
          10. Pan American Health Organization. 1972. First Pan American Symposium on Paracoccidioidomycosis. Medellin Colombia 25- 27, October, 1971. Scientific Publication No. 254. Washington D.C., World Health Organization.
          11. Restrepo MA. 1966. La prueba inmunodifusión en la diagnóstica de la paracoccidioidomicosis. Sabouraudia, 4:223-230.
          12. Restrepo MA, Schneidau JD. Nature of the skin reactive principal in culture filtrates prepared from P. brasiliensis. J. Bacteriol 1967; 91:1741-1748.
          13. Restrepo M A, Greer DL. et al. 1971.Relationship between the environment and paracoccidioidomycosis. Ref. 41, pp. 84-91.
          14. Yarsabal, L. A. Pathogenesis of paracoccidioidomycosis in man. 1971; Ref. 41 pp. 261-270.
          15. Mandel, Bennetth and Dolin . Principes and Practice of Infections Disease. 6" edition. Chapter 266. Paracoccidioidomycosis brasiliensis. 2005.
          16. San-Blas G, Nino-Vega G, Iturriaga T.: Paracoccidioides brasiliensis and paracoccidioidomycosis: molecular approaches to morphogenesis, Diagnosis, Epidemiology, Taxonomy and genetics. Med Mycol 2002; 40:225-242.
          17. Lacaz CS, Porto E, Martins JEC, et al: paracoccidioidomicose. In: Lacaz CS, Porto E, Martins JEC, et al. Tratado de micologia medica Lacaz, 9" ed. Sao Paulo: Sarvier; 2002:639-729.
          18. CockAM, Cano LE, Velez D, et al: fribrotic sequelae in pulmonary paracoccidioidomyosis: Histopathological aspects in BALB/C mice infected with viable and non-viable propacules. Rev Inst Med Trop Sao Paulo 2002; 42:59-66.
          19. Flavia-Popi AF, Lopes JD, Mariano M: GP 43 from paracoccidioides brasiliensis inhibits macrophage funtionas: An evasion mechanisn of the fungus. Cell inmunol 2002; 218: 87-94.
          20. Restrepo A. Morpholagical aspects of paracoccidioides brasiliensis in ymph nodes: implication for the prolonged latency of paracoccidioidomycosis?. Med Mycol 2000; 38: 317-322.
          21. Camargo ZP, Franco MF: Current knowledge on pathogenesis and immnudiagnosis of paracoccidioidomycosis. Rev Iberon Micol 2000; 17:41-48.
          22. Kashino SS, Fazioly RA, Cafalli-Favati C, et al: Resistance to paracoccidioides brasiliensis infection is linked to a preferential Th1 immune response, whereas susceptibility is associated with absence of IFN-gamma production. J Inteferon Cytokine Res 2000; 20:89-97.
          23. Tobon AM, Agudelo CA, Osorio ML, et al. Residual pulmonary abnormalities in adult patients with chronic paracoccidioidoVOLUMEN 19 N* 4 mycosis: prolonged follow-up after itraconozole therapy. Clin infect dis 2003; 37: 898-904.
          24. Bicalho RN, Espirito Santo MF, Aguilar MCF, et al: oral paracoccidioidomycosis: A retrospective study of 62 brazilians patiens. Oral dis 2001; 7:56-60.
          25. SantAnna GD, Mauri M, Arrarte JL, Camargo H. Laryngeal manisfestations of paracoccidioidomycosis (South American Blastomycosis). Arch Otolaryngol Head neck Surg 1999; 125: 1375-1378.
          26. Camargo ZP, Baruzzi RG, Maeda SM, Florino MC. Antigenic relationship between Loboa loboil and paracoccidioides brasiliensis by serological methods. Med. Mycol. 1998; 36:413- 417
          27. Vilani-Moreno PO, Opromolla DVA. Determinacao da viabilidade do paracoccioides Loboi em biopsias de pacientes portadores de doenca de Jorge Lobo. Ann. Bras. Dermatol. (Rio de Janeiro) 1997; 72:433-437.
          28. Herr RA, Tarcha EJ, Tarborda P R, Taylor JW, Ajello L, Mendoza L. Phylogenetic Analysis of Lacazia Loboi place this previously uncharacterized pathogen within the dimorphic Onygenales. J. Clin. Microbiol 2001; 39:309-314.
          29. Vitela R, Mendoza L., Rosa PS., Fernandez AF, Madeira S, Araujo DV., de Resende M. A. Molecular Model for Studying the Uncultivated Fungal Pathogen Lacazia loboi. Journal of Clinical Microbiology. August 2005. Pp. 3656-3651.
          30. De Camargo ZP, De Franco MF. Current knowledge on Pathogenesis and immunogiagnosis of paracoccidioidomycosis. Rev. Iberoam Micol 2000; 17:41-48.
          31. Parise-Fortes MR, Marques SA, Soares AM, Kuroyawa CS, Maques ME, Peracoli MT. Cytokines released From blood monovytes and expressed in mucocutaneos lesions of patients with paracoccidioidomycosis evaluated before and during trimethoprim-sulfamethoxazole treatment. Br J Dermatology 2006; 154(4):643-50
          32. Ferreira KS, Almeida SR. Immunization of susceptible mice with gp43-pulsed dendritic cells induce increase of pulmonary Paracoccidioidomycosis. Immunol Letters 2006; 103:121-126.
          33. De Almeida SR, De Moraes JZ, De Camargo ZP, Gesztesi JL, Mariano M, Lopes JD. Pattern of immune response to GP43 from paracoccidioides brasiliensis in susceptible resistant mice is influenced by antigen-presenting cell. Cell Immunol. 1998 Nov 25; 190(1):68-76.
          34. Mamoni RL, Nouer SA, Oliveira SJ, Musatti CC, Rossi CL, Camargo ZP, Blotta MH. Enhanced production of specific IgGA, IgE. IgA and TGF-beta in sera from patients with juvenile form of paracoccidioidomycosis. Med Mycol 2002; 40:153-9.
          Sistema OJS 3.4.0.7 - Metabiblioteca |